Diagnostic classification of cancer using DNA microarrays and artificial intelligence

Annals of the New York Academy of Sciences

Volumn 1020, Issue , 2004, Pages 49-66

  Greer, Braden T ^a   Khan, Javed ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Artificial intelligence; Artificial neural networks; Microarray; Support vector machines

Indexed keywords

ESTROGEN RECEPTOR;

ANALYSIS OF VARIANCE; ARTIFICIAL INTELLIGENCE; ARTIFICIAL NEURAL NETWORK; BIOINFORMATICS; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CLUSTER ANALYSIS; COMPUTER ANALYSIS; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION SYSTEM; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC MARKER; HUMAN; MACHINE; MOLECULAR MODEL; TECHNIQUE; TUMOR CELL;

EID: 2942514670     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1310.007     Document Type: Conference Paper

References (17)

1. KHAN, J. et al. 2001. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 7: 673-679.
2. GRUVBERGER, S. et al. 2001. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61: 5979-5984.
3. XU, Y. et al. 2002. Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res. 62: 3493-3497.
4. FUREY, T.S. et al. 2000. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16: 906-914.
5. VAN'T VEER, L.J. et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
6. WEST, M. et al. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA 98: 11462-11467.
7. SHIPP, M.A. et al. 2002. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8: 68-74.
8. O'NEILL, M.C. & L. SONG. 2003. Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect. BMC Bioinformatics 4: 13.
9. RINGNER, M., C. PETERSON & J. KHAN. 2002. Analyzing array data using supervised methods. Pharmacogenomics 3: 403-415.
10. QUACKENBUSH, J. 2001. Computational analysis of microarray data. Nat. Rev. Genet. 2: 418-427.
11. HAYKIN, S. 1999. Neural Networks: A Comprehensive Foundation. Prentice-Hall. Upper Saddle River, NJ.
12. BITTNER, M. et al. 2000. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540.
13. SHEK, L.L. & W. GODOLPHIN. 1988. Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. Cancer Res. 48: 5565-5569.
14. OSBORNE, C.K. 1998. Steroid hormone receptors in breast cancer management. Breast Cancer Res. Treat. 51: 227-238.
15. PARL, F.F. 2000. Estrogens, Estrogen Receptor, and Breast Cancer. IOS Press. Amsterdam.
16. TUSHER, V.G., R. TIBSHIRANI & G. CHU. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
17. ALIZADEH, A.A. et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511.